Navigation Links
PSA Test's Overall Benefit Still Unclear: Study
Date:8/15/2012

By Maureen Salamon
HealthDay Reporter

WEDNESDAY, Aug. 15 (HealthDay News) -- The latest entry in the scientific debate over the value of prostate-specific antigen (PSA) testing suggests its overall worth remains far from clear.

Using statistical modeling, Dutch researchers concluded its benefits are diminished by lost quality of life from serious side effects and the decision whether to screen should be left to men and their doctors.

In their study, the study author predicted that annual PSA tests for men aged 55 to 69 would result in nine fewer prostate cancer deaths (28 percent) for every 1,000 men screened.

But they were also able to quantify harm and survival on the same scale by calculating quality-adjusted life years.

With harms such as impotence and incontinence factored in, "the disadvantages of screening diminish the benefits [of added lifespan] by 20 percent," said study author Eveline Heijnsdijk, a researcher at the department of public health of Erasmus Medical Center in Rotterdam.

"Individuals and clinicians have to decide themselves whether the benefits outweigh the harms," Heijnsdijk said.

The quality-adjusted life year index is a measure that assesses the value of a medical intervention. PSA is a protein in cells of the prostate gland, and the higher a man's PSA the more likely it is he has cancer.

Dr. Louis Potters, chair of radiation medicine at North Shore-LIJ Health System in New Hyde Park, N.Y., agreed the findings suggest a need to consider each case individually.

"Once again, these results confound any definitive conclusion," said Potters. "This particular study further hardens the argument that you do need to think about it, you do need to personalize it and there isn't a one-size-fits-all approach, as disappointing as it might be for each side of the argument."

The study is published Aug. 16 in the New England Journal of Medicine.

In May, the U.S. Preventive Services Task Force recommended against routine PSA screening, saying too many non-dangerous cancers were being treated aggressively and resulting in unnecessary harm.

But a July study in the journal Cancer found that not screening American men would triple the number developing advanced cancer, and the American Society of Clinical Oncology recommended that men with a life expectancy of more than 10 years talk with their doctors about getting the test.

This new analysis uses information gleaned from the European Randomized Study of Screening for Prostate Cancer, which evaluated the effect of PSA screening on prostate cancer mortality in 162,000 men in seven countries.

The scientists confirmed that PSA screening would save lives, and using a quality-adjusted life year index they concluded that 73 total life-years would be gained for every 1,000 men screened. However, only 56 of the 73 life-years gained would be considered "quality" years once adjusted for adverse effects related to overdiagnosis and treatment of cancers that would never turn lethal.

Potters asserted that the argument whether or not to screen would "go away" if more patients underwent surveillance of their prostate cancer rather than active treatments such as prostate removal or radiation -- therapies the study noted leave between 42 percent and 88 percent of men impotent.

Between 40 percent and 48 percent of men diagnosed with prostate cancer are eligible for surveillance, which closely monitors their cancer, he said.

"That's the opportunity that's sort of lacking," he added. "We're getting blinded by the argument of screening when I think the argument is really over treatment."

More information

The U.S. National Cancer Institute offers a fact sheet about PSA testing.

SOURCES: Eveline Heijnsdijk, Ph.D., researcher, department of public health, Erasmus Medical Center, Rotterdam, the Netherlands; Louis Potters, M.D., chair, radiation medicine, North Shore-LIJ Health System, New Hyde Park, N.Y.; Aug. 16, 2012, New England Journal of Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Imaging Tests Up Among Advanced Cancer Patients
2. A new genre of diagnostic tests for the era of personalized medicine
3. Many Teens With High Blood Pressure Dont Get Needed Tests
4. HIV suppression not as good as previously thought, largest study of viral-load blood tests show
5. Every 3 Years Is Best for Stomach Cancer Tests: Study
6. 40,000 Arizona student athletes receive concussion tests from Mayo Clinic
7. 2 new vitamin D blood tests are often highly inaccurate, researchers say
8. Super-sensitive tests could detect diseases earlier
9. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
10. U.S. Advisers Say No to Routine PSA Tests for Prostate Cancer
11. Better tests for sleeping sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... ... Finally, a bruise cream that really works. Originally designed to reduce ... post-surgical treatment plans of a variety of other procedures including, but not limited to, ... bruising and causes a rapid resolution of bruising and inflammatory changes compared to no ...
(Date:6/24/2016)... ... 2016 , ... Dr. Seema Daulat, a native Texan and University of Texas ... as of July 13, 2016. , Dr. Daulat earned her Doctorate of Medicine (MD) ... volunteered at the Agape Clinic serving Dallas’ underprivileged community. , Following medical school, Dr. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... Tenn. , June 23, 2016 /PRNewswire/ ... automating, integrating and transforming the patient payment ... of several innovative new products and services ... of its revenue cycle offerings. These award-winning ... more efficient workflows, remain compliant in an ...
Breaking Medicine Technology: